Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study
- PMID: 30688717
- DOI: 10.1097/CCM.0000000000003654
Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study
Abstract
Objectives: Although the effect of antihypertensive agents on sepsis has been studied, evidence for survival benefit was limited in the literature. We investigated differences in sepsis-related outcomes depending on the antihypertensive drugs given prior to sepsis in patients with hypertension.
Design: Population-based cohort study.
Setting: Sample cohort Database of the National Health Insurance Service from 2003 to 2013 in South Korea.
Patients: Patients over 30 years old who were diagnosed with sepsis after receiving hypertension treatment.
Interventions: None.
Measurements and main results: Primary outcomes, 30-day and 90-day mortality rates, were analyzed for differences among three representative antihypertensive medications: angiotensin- converting enzyme inhibitors or angiotensin II receptor blockers, calcium channel blockers, and thiazides. In total, 4,549 patients diagnosed with hypertension prior to hospitalization for sepsis were identified. The 30-day mortality was significantly higher among patients who did not receive any medications within 1 month before sepsis (36.8%) than among patients who did (32.0%; p < 0.001). The risk for 90-days mortality was significantly lower in prior angiotensin-converting enzyme inhibitors or angiotensin II receptor blocker users (reference) than in other drug users (odds ratio, 1.27; 95% CI, 1.07-1.52). There was no difference in the risk for 30-day and 90-day mortality depending on whether calcium channel blockers or thiazides were used. Use of calcium channel blockers was associated with a decreased risk for inotropic agent administration, compared with those of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (odds ratio, 1.23; 95% CI, 1.05-1.44) and thiazides (odds ratio, 1.33; 95% CI, 1.12-1.58).
Conclusions: In patients with sepsis, lower mortality rate was associated with prior use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers not with use of calcium channel blockers or thiazides. The requirement of inotropic agents was significantly lower in prior use of calcium channel blockers, although the survival benefits were not prominent.
Comment in
-
Sepsis Epidemiology From Administrative Data: Going, Going….Crit Care Med. 2019 May;47(5):739-740. doi: 10.1097/CCM.0000000000003690. Crit Care Med. 2019. PMID: 30985460 No abstract available.
Similar articles
-
Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service.J Korean Med Sci. 2020 Jun 29;35(25):e232. doi: 10.3346/jkms.2020.35.e232. J Korean Med Sci. 2020. PMID: 32597045 Free PMC article.
-
Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs).Shock. 2020 Apr;53(4):407-415. doi: 10.1097/SHK.0000000000001382. Shock. 2020. PMID: 31135703
-
Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.Hypertension. 2021 Mar 3;77(3):833-842. doi: 10.1161/HYPERTENSIONAHA.120.16314. Epub 2021 Jan 11. Hypertension. 2021. PMID: 33423528 Free PMC article.
-
Antihypertensive drugs demonstrate varying levels of hip fracture risk: A systematic review and meta-analysis.Injury. 2022 Mar;53(3):1098-1107. doi: 10.1016/j.injury.2021.09.036. Epub 2021 Sep 28. Injury. 2022. PMID: 34627629
-
Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.J Am Pharm Assoc (2003). 2010 Sep-Oct;50(5):e116-25. doi: 10.1331/JAPhA.2010.09234. J Am Pharm Assoc (2003). 2010. PMID: 20833609 Review.
Cited by
-
Noninvasive measurements of hemodynamic, autonomic and endothelial function as predictors of mortality in sepsis: A prospective cohort study.PLoS One. 2019 Mar 11;14(3):e0213239. doi: 10.1371/journal.pone.0213239. eCollection 2019. PLoS One. 2019. PMID: 30856206 Free PMC article.
-
Effects of renin-angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials.Eur Heart J Cardiovasc Pharmacother. 2024 Jan 5;10(1):68-80. doi: 10.1093/ehjcvp/pvad067. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 37740450 Free PMC article.
-
Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis.Korean J Intern Med. 2021 Mar;36(2):371-381. doi: 10.3904/kjim.2019.262. Epub 2020 Apr 9. Korean J Intern Med. 2021. PMID: 32264653 Free PMC article.
-
Association Between Prior Calcium Channel Blocker Use and Mortality in Septic Patients: A Meta-Analysis of Cohort Studies.Front Pharmacol. 2021 May 25;12:628825. doi: 10.3389/fphar.2021.628825. eCollection 2021. Front Pharmacol. 2021. PMID: 34113248 Free PMC article. Review.
-
Endocrine and metabolic alterations in response to systemic inflammation and sepsis: a review article.Mol Med. 2025 Jan 21;31(1):16. doi: 10.1186/s10020-025-01074-z. Mol Med. 2025. PMID: 39838305 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical